ReviewEmerging infectious diseases2009
Population mobility, globalization, and antimicrobial drug resistance.
Review in Emerging infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: a systematic review and meta-analysis.BMC pharmacology & toxicology · 2018Pooled it
- Targeting Zoonotic Spillover Drivers for Global Pandemic Prevention: A Narrative Review.Microorganisms · 2026Review
- The Structural Imbalance and Trajectory of Chinese National Policies on Medical-Preventive Integration: A Three-Dimensional Analysis of Policy Instruments (2015-2025).Healthcare (Basel, Switzerland) · 2026Article
- Selective bactericidal efficacy of 465-nm blue light phototherapy against standard and canine wound pathogens: AnVeterinary world · 2025Article
- Epidemiological feature of imported malaria in Taiwan during the 2014-to-2020 period.Medicine · 2025Article
- Molecular epidemiology of methicillin-resistantFrontiers in microbiology · 2025Review
- Microbiome Geographic Population Structure (mGPS) Detects Fine-Scale Geography.Genome biology and evolution · 2024Article
- Elucidating the antimicrobial and anticarcinogenic potential of methanolic and water extracts of edibleFood science & nutrition · 2024Article
- ICU Admission Risk Factors for Latinx COVID-19 Patients at a U.S.-Mexico Border Hospital.Journal of racial and ethnic health disparities · 2023Observational
- Leveraging the COVID-19 pandemic as a natural experiment to assess changes in antibiotic use and antibiotic-resistant E. coli carriage in semi-rural Ecuador.Scientific reports · 2023Observational
- Review
- Human disturbance increases coronavirus prevalence in bats.Science advances · 2023Article
- Molecular Epidemiology of Clinical Carbapenem-ResistantTropical medicine and infectious disease · 2022Article
- The importance of community during rapid development: The influence of social networks on acute gastrointestinal illness in rural Ecuador.SSM - population health · 2022Article
- Effects of active compounds fromRSC advances · 2022Article
- Future developments in training.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021Review
- Antibiotic resistance in the environment: a critical insight on its occurrence, fate, and eco-toxicity.Environmental science and pollution research international · 2021Review
- Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing UropathogenicAntibiotics (Basel, Switzerland) · 2021Article
- Proximal junctional kyphosis post tuberculous spine corrective surgery in paediatric patients.Spine deformity · 2021Article
- Paeonol Attenuates Quorum-Sensing Regulated Virulence and Biofilm Formation inFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Population mobility is a main factor in globalization of public health threats and risks, specifically distribution of antimicrobial drug-resistant organisms. Drug resistance is a major risk in healthcare settings and is emerging as a problem in community-acquired infections. Traditional health policy approaches have focused on diseases of global public health significance such as tuberculosis, yellow fever, and cholera; however, new diseases and resistant organisms challenge existing approaches. Clinical implications and health policy challenges associated with movement of persons across barriers permeable to products, pathogens, and toxins (e.g., geopolitical borders, patient care environments) are complex. Outcomes are complicated by high numbers of persons who move across disparate and diverse settings of disease threat and risk. Existing policies and processes lack design and capacity to prevent or mitigate adverse health outcomes. We propose an approach to global public health risk management that integrates population factors with effective and timely application of policies and processes.
Indexed as
Identifiers
19891858PMC2857230What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.